XML 57 R26.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation Plans (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity for the nine months ended September 30, 2025 and 2024, respectively, for the 2019 Plan:
OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of January 1, 202516,136,045 $1.52 
Granted9,937,100 $0.78 
Exercised— $— — 
Forfeited or expired(344,648)$3.49 
Outstanding as of September 30, 202525,728,497 $1.21 8.56$1,058,962 
Options exercisable as of September 30, 20258,105,832 $1.62 7.14$39,947 
OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of January 1, 20246,196,140 $7.15 
Granted5,715,349 $1.23 
Exercised— $— 
Repricing modification— $9.55 
Forfeited or expired(365,351)$2.08 
Outstanding as of September 30, 202411,546,138 $1.63 8.33$2,794,286 
Options exercisable as of September 30, 20244,171,969 $2.09 7.07$329,830 
Schedule of Valuation Assumptions Used
The following table summarizes the key assumptions used in estimating the fair value of the SARs at issuance and on September 30, 2025:

July 7, 2025September 30, 2025
Expected term (years)
1-2.90
0.90-2.80
Risk-free interest rate
4.17%-4.38%
3.79%-4.11%
Stock price volatility
85%-115%
85%-115%
Probability (1)
50%-50%
50%-50%
Dividend rate— %— %

(1) Scenario probability was based on timing expectations of the Company that a corporate transaction occurring was estimated at 50%; and a corporate transaction not occurring at 50%.
The following are the underlying assumptions used in the Black-Scholes-Merton option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:
Nine Months Ended September 30,
20252024
Risk-free interest rate4.14%4.11%
Expected dividend yield0%0%
Expected volatility116.0%100.0%
Expected term of options (years)5.915.95
The following table summarizes the key assumptions used in estimating the fair value of the SARs at issuance and on September 30, 2025:

July 7, 2025September 30, 2025
Expected term (years)
1-2.90
0.90-2.80
Risk-free interest rate
4.17%-4.38%
3.79%-4.11%
Stock price volatility
85%-115%
85%-115%
Probability (1)
50%-50%
50%-50%
Dividend rate— %— %

(1) Scenario probability was based on timing expectations of the Company that a corporate transaction occurring was estimated at 50%; and a corporate transaction not occurring at 50%.
Schedule of SARs Activity
The Company’s SARs activity is as follows:

SARs grantsSharesWeighted average exercise priceWeighted average remaining contractual term (years)Aggregate intrinsic value
Balance at January 1, 2025— $—
SARs granted34,998,367 $0.765
SARs forfeited or expired— $—
Balance at September 30, 202534,998,367 $0.7659.76$4,080,809
Exercisable at September 30, 2025— $—$—
Schedule of Stock-Based Compensation Expense for Stock Awards Recognized
Total stock-based compensation expense for all stock awards recognized in the accompanying unaudited condensed consolidated statements of operations is as follows:
 Three Months
 Ended September 30,
Nine Months
 Ended September 30,
 2025202420252024
Research and development$1,539,000 $811,000 $3,131,000 $2,816,000 
General and administrative2,075,000 1,099,000 4,424,000 3,726,000 
Total$3,614,000 $1,910,000 $7,555,000 $6,542,000